UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045249
Receipt number R000049386
Scientific Title Research study for microsatellite instability in malignancy in hepato-biliary-pancreatic field (KHBO 1903-1-2)
Date of disclosure of the study information 2021/08/25
Last modified on 2021/08/24 19:17:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research study for microsatellite instability in malignancy in hepato-biliary-pancreatic field (KHBO 1903-1-2)

Acronym

MHBPKHBO1903-1-2

Scientific Title

Research study for microsatellite instability in malignancy in hepato-biliary-pancreatic field (KHBO 1903-1-2)

Scientific Title:Acronym

MHBPKHBO1903-1-2

Region

Japan


Condition

Condition

Malignancy in hepato-biliary-pancreatic field

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study is aimed to investigate the proportion of high microsatellite instability in malignancy in hepato-biliary-pancreatic field and characteristic of patients with malignancy with high microsatellite instability for the appropriate treatment selection.

Basic objectives2

Others

Basic objectives -Others

None

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The proportion of high microsatellite instability in malignancy in hepato-biliary-pancreatic field

Key secondary outcomes

characteristic of patients with malignancy with high microsatellite instability


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who underwent test for microsatellite instability between 2019 and 2022

Key exclusion criteria

Patients who do not agree for this study

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Shoji
Middle name
Last name Kubo

Organization

Osaka City University

Division name

Department of Hepato-Biliary-Pancreatic Surgery

Zip code

545-8585

Address

1-4-3 Asahimachi, Abeno-ku, Osaka

TEL

06-6645-3841

Email

m7696493@msic.med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name Shoji
Middle name
Last name Kubo

Organization

Osaka City University

Division name

Department of Hepato-Biliary-Pancreatic Surgery

Zip code

545-8585

Address

1-4-3 Asahimachi, Abeno-ku, Osaka

TEL

06-6645-3841

Homepage URL

http://www.med.osaka-cu.ac.jp/ocum-surgery/abdomen/stuff.html

Email

m7696493@msic.med.osaka-cu.ac.jp


Sponsor or person

Institute

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University

Institute

Department

Personal name



Funding Source

Organization

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kansai Hepato-Biliary Oncology Group

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka City University

Address

1-2-7 Asahimachi, Abeno-ku, Osaka

Tel

06-6645-3456

Email

ethics@med.osaka-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪国際がんセンター、京都大学、大阪大学、山口大学、兵庫医科大学、関西医科大学、国立病院機構大阪医療センター、大阪労災病院、関西電力病院、市立東大阪医療センター、ベルランド総合病院


Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 05 Month 19 Day

Date of IRB

2020 Year 07 Month 29 Day

Anticipated trial start date

2021 Year 03 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cohort study


Management information

Registered date

2021 Year 08 Month 24 Day

Last modified on

2021 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049386


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name